טוען...
The burden of adverse drug events
Drug safety should be considered as part of the balance between benefit and risk, and represents a burden to the patient, the healthcare professional, the regulator and industry. Each of these has a different view on adverse drug reactions and these are discussed in this article.
שמור ב:
| הוצא לאור ב: | Br J Clin Pharmacol |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4594720/ https://ncbi.nlm.nih.gov/pubmed/25205165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12507 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|